Genomewide association for schizophrenia in the CATIE study: results of stage 1 - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1038/mp.2008.25. Epub 2008 Mar 18.
D Lin, J-Y Tzeng, E van den Oord, D Perkins, T S Stroup, M Wagner, S Lee, F A Wright, F Zou, W Liu, A M Downing, J Lieberman, S L Close
Affiliations
- PMID: 18347602
- PMCID: PMC3910086
- DOI: 10.1038/mp.2008.25
Randomized Controlled Trial
Genomewide association for schizophrenia in the CATIE study: results of stage 1
P F Sullivan et al. Mol Psychiatry. 2008 Jun.
Erratum in
- Mol Psychiatry. 2009 Dec;14(12):1144
Abstract
Little is known for certain about the genetics of schizophrenia. The advent of genomewide association has been widely anticipated as a promising means to identify reproducible DNA sequence variation associated with this important and debilitating disorder. A total of 738 cases with DSM-IV schizophrenia (all participants in the CATIE study) and 733 group-matched controls were genotyped for 492,900 single-nucleotide polymorphisms (SNPs) using the Affymetrix 500K two-chip genotyping platform plus a custom 164K fill-in chip. Following multiple quality control steps for both subjects and SNPs, logistic regression analyses were used to assess the evidence for association of all SNPs with schizophrenia. We identified a number of promising SNPs for follow-up studies, although no SNP or multimarker combination of SNPs achieved genomewide statistical significance. Although a few signals coincided with genomic regions previously implicated in schizophrenia, chance could not be excluded. These data do not provide evidence for the involvement of any genomic region with schizophrenia detectable with moderate sample size. However, a planned genomewide association study for response phenotypes and inclusion of individual phenotype and genotype data from this study in meta-analyses hold promise for eventual identification of susceptibility and protective variants.
Figures
Figure 1
Results of single-marker association tests of case-control status for 492,900 SNPs. Panel A. shows the QQ plot (77) of the observed p-values, −log10 (p), versus those expected by chance, −log10(iL+1), where p is the asymptotic p-value from the additive test that the SNP coefficient is zero, i is the rank for each SNP p-value (1=smallest, L=largest), and L is the number of SNPs. The dashed lines show the expected 95% probability interval for ordered p-values. Panel B depicts −log10 (p) for the 26,738 SNPs with p-values < 0.05 in the context of the human genome in order to make spatial clustering more evident.
Similar articles
- Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
Carroll LS, Williams NM, Moskvina V, Russell E, Norton N, Williams HJ, Peirce T, Georgieva L, Dwyer S, Grozeva D, Greene E, Farmer A, McGuffin P, Morris DW, Corvin A, Gill M, Rujescu D, Sham P, Holmans P, Jones I, Kirov G, Craddock N, O'Donovan MC, Owen MJ. Carroll LS, et al. Mol Psychiatry. 2010 Nov;15(11):1101-11. doi: 10.1038/mp.2009.96. Epub 2009 Sep 29. Mol Psychiatry. 2010. PMID: 19786960 - Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.
Ikeda M, Tomita Y, Mouri A, Koga M, Okochi T, Yoshimura R, Yamanouchi Y, Kinoshita Y, Hashimoto R, Williams HJ, Takeda M, Nakamura J, Nabeshima T, Owen MJ, O'Donovan MC, Honda H, Arinami T, Ozaki N, Iwata N. Ikeda M, et al. Biol Psychiatry. 2010 Feb 1;67(3):263-9. doi: 10.1016/j.biopsych.2009.08.030. Epub 2009 Oct 22. Biol Psychiatry. 2010. PMID: 19850283 Clinical Trial. - Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.
Adkins DE, Aberg K, McClay JL, Bukszár J, Zhao Z, Jia P, Stroup TS, Perkins D, McEvoy JP, Lieberman JA, Sullivan PF, van den Oord EJ. Adkins DE, et al. Mol Psychiatry. 2011 Mar;16(3):321-32. doi: 10.1038/mp.2010.14. Epub 2010 Mar 2. Mol Psychiatry. 2011. PMID: 20195266 Free PMC article. Clinical Trial. - Comparison of multimarker logistic regression models, with application to a genomewide scan of schizophrenia.
Wason JM, Dudbridge F. Wason JM, et al. BMC Genet. 2010 Sep 9;11:80. doi: 10.1186/1471-2156-11-80. BMC Genet. 2010. PMID: 20828390 Free PMC article. - Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.
Werner FM, Coveñas R. Werner FM, et al. Curr Pharm Des. 2021 Oct 5;27(30):3281-3292. doi: 10.2174/1381612827666210215151333. Curr Pharm Des. 2021. PMID: 33588721 Review.
Cited by
- Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry.
Del Casale A, Sarli G, Bargagna P, Polidori L, Alcibiade A, Zoppi T, Borro M, Gentile G, Zocchi C, Ferracuti S, Preissner R, Simmaco M, Pompili M. Del Casale A, et al. Curr Neuropharmacol. 2023;21(12):2395-2408. doi: 10.2174/1570159X21666230808170123. Curr Neuropharmacol. 2023. PMID: 37559539 Free PMC article. - Genome-wide association study identified six loci associated with adverse drug reactions to aripiprazole in schizophrenia patients.
Wang X, Mei D, Lu Z, Zhang Y, Sun Y, Lu T, Yan H, Yue W. Wang X, et al. Schizophrenia (Heidelb). 2023 Jul 25;9(1):44. doi: 10.1038/s41537-023-00369-6. Schizophrenia (Heidelb). 2023. PMID: 37491364 Free PMC article. - Analysis of structural variation among inbred mouse strains.
Arslan A, Fang Z, Wang M, Tan Y, Cheng Z, Chen X, Guan Y, J Pisani L, Yoo B, Bejerano G, Peltz G. Arslan A, et al. BMC Genomics. 2023 Mar 2;24(1):97. doi: 10.1186/s12864-023-09197-5. BMC Genomics. 2023. PMID: 36864393 Free PMC article. - Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia.
Fabbri C, Leggio GM, Drago F, Serretti A. Fabbri C, et al. Mol Genet Genomic Med. 2022 Jun;10(6):e1942. doi: 10.1002/mgg3.1942. Epub 2022 Apr 30. Mol Genet Genomic Med. 2022. PMID: 35488718 Free PMC article. - Artificial image objects for classification of schizophrenia with GWAS-selected SNVs and convolutional neural network.
Chen X, Chen DG, Zhao Z, Zhan J, Ji C, Chen J. Chen X, et al. Patterns (N Y). 2021 Jun 30;2(8):100303. doi: 10.1016/j.patter.2021.100303. eCollection 2021 Aug 13. Patterns (N Y). 2021. PMID: 34430925 Free PMC article.
References
- Lichtenstein P, Bjork C, Hultman CM, Scolnick EM, Sklar P, Sullivan PF. Recurrence risks for schizophrenia in a Swedish national cohort. Psychological Medicine. 2006;36:1417–1426. - PubMed
- Gottesman II, Shields J. Schizophrenia: The Epigenetic Puzzle. Cambridge, UK: Cambridge University Press; 1982.
- Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry. 2003;60:1187–1192. - PubMed
- Falconer DS, Mackay TFC. Introduction to Quantitative Genetics. 4th ed. London: Longman Group Ltd.; 1996.
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH074027-01A1/MH/NIMH NIH HHS/United States
- MH067257/MH/NIMH NIH HHS/United States
- R01 MH067257/MH/NIMH NIH HHS/United States
- R01 MH060870/MH/NIMH NIH HHS/United States
- MH059588/MH/NIMH NIH HHS/United States
- R01 MH059588/MH/NIMH NIH HHS/United States
- R01 MH074027/MH/NIMH NIH HHS/United States
- R01 MH061675/MH/NIMH NIH HHS/United States
- MH061675/MH/NIMH NIH HHS/United States
- MH60870/MH/NIMH NIH HHS/United States
- MH59586/MH/NIMH NIH HHS/United States
- R01 MH077139/MH/NIMH NIH HHS/United States
- MH059571/MH/NIMH NIH HHS/United States
- R01 MH059571/MH/NIMH NIH HHS/United States
- R01 GM074175/GM/NIGMS NIH HHS/United States
- R01 MH059565/MH/NIMH NIH HHS/United States
- R01 MH059587/MH/NIMH NIH HHS/United States
- P30 HD003110/HD/NICHD NIH HHS/United States
- MH059565/MH/NIMH NIH HHS/United States
- R01 MH059586/MH/NIMH NIH HHS/United States
- R01 MH059566/MH/NIMH NIH HHS/United States
- N01 MH90001/MH/NIMH NIH HHS/United States
- GM074175/GM/NIGMS NIH HHS/United States
- MH59566/MH/NIMH NIH HHS/United States
- U01 MH060879/MH/NIMH NIH HHS/United States
- R01 MH060879/MH/NIMH NIH HHS/United States
- MH59587/MH/NIMH NIH HHS/United States
- R01 MH074027-02/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical